Pharmacokinetic study of intravenous busulfan in haematopoietic stem cell transplantation: results of a prospective study with 25 children

被引:0
|
作者
Nagatoshi, Y. [1 ]
Okamoto, Y. [2 ]
Kosaka, Y. [3 ]
Kikuchi, A. [4 ]
Kato, S. [5 ]
Kigasawa, H. [6 ]
Horikoshi, Y. [7 ]
Chayama, K. [8 ]
Kaneda, M. [2 ]
Mori, T. [9 ]
Mugishima, H. [10 ]
Kawano, Y. [2 ]
机构
[1] Kyushu Canc Ctr, Fukuoka, Japan
[2] Kagoshima Univ, Kagoshima 890, Japan
[3] Hyougo Prefectural Kobe Childrens Hosp, Hyogo, Japan
[4] Saitama Childrens Med Ctr, Saitama, Japan
[5] Tokai Univ, Kanagawa 2591100, Japan
[6] Kanagawa Childrens Med Ctr, Kanagawa, Japan
[7] Shizuoka Childrens Hosp, Shizuoka, Japan
[8] Okayama Univ, Okayama, Japan
[9] Natl Ctr Child Hlth & Dev, Tokyo, Japan
[10] Nihon Univ, Tokyo, Japan
关键词
D O I
暂无
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
引用
收藏
页码:S264 / S265
页数:2
相关论文
共 50 条
  • [1] Prospective pharmacokinetic study of intravenous busulfan in hematopoietic stem cell transplantation in 25 children
    Okamoto, Yasuhiro
    Nagatoshi, Yoshihisa
    Kosaka, Yoshiyuki
    Kikuchi, Akira
    Kato, Shunichi
    Kigasawa, Hisato
    Horikoshi, Yasuo
    Oda, Megumi
    Kaneda, Makoto
    Mori, Tetsuya
    Mugishima, Hideo
    Tsuchida, Masahiro
    Taniguchi, Shuichi
    Kawano, Yoshifumi
    PEDIATRIC TRANSPLANTATION, 2014, 18 (03) : 294 - 301
  • [2] Intravenous busulfan in adults prior to haematopoietic stem cell transplantation: a population pharmacokinetic study
    Nguyen, L
    Leger, F
    Lennon, S
    Puozzo, C
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2006, 57 (02) : 191 - 198
  • [3] Intravenous busulfan in adults prior to haematopoietic stem cell transplantation: a population pharmacokinetic study
    L. Nguyen
    F. Leger
    S. Lennon
    C. Puozzo
    Cancer Chemotherapy and Pharmacology, 2006, 57 : 191 - 198
  • [4] Intravenous busulfan in paediatric haematopoietic stem cell transplantation
    Kuskonmaz, B.
    Unal, S.
    Akan, A.
    Cetin, N.
    Akyol, F.
    Cetin, M.
    Tezcan, I.
    Uckan, D.
    BONE MARROW TRANSPLANTATION, 2007, 39 : S304 - S304
  • [5] Association between busulfan exposure and outcome in children receiving intravenous busulfan before haematopoietic stem cell transplantation
    Ansari, M.
    Theoret, Y.
    Rezgui, M.
    Mezziani, S.
    Desjean, C.
    Vachon, M.
    Labuda, M.
    Champagne, M.
    Duval, M.
    Peters, C.
    Krajinovic, M.
    Bittencourt, H.
    BONE MARROW TRANSPLANTATION, 2012, 47 : S40 - S41
  • [6] Precision dosing of intravenous busulfan in pediatric hematopoietic stem cell transplantation: Results from a multicenter population pharmacokinetic study
    Ben Hassine, Khalil
    Nava, Tiago
    Theoret, Yves
    Nath, Christa E.
    Daali, Youssef
    Kassir, Nastya
    Lewis, Victor
    Bredius, Robbert G. M.
    Shaw, Peter J.
    Bittencourt, Henrique
    Krajinovic, Maja
    Uppugunduri, Chakradhara Rao Satyanarayana
    Ansari, Marc
    CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY, 2021, 10 (09): : 1043 - 1056
  • [7] Intravenous busulfan for allogeneic hematopoietic stem cell transplantation in infants: clinical and pharmacokinetic results
    Dalle, JH
    Wall, D
    Theoret, Y
    Duval, M
    Shaw, L
    Larocque, D
    Taylor, C
    Gardiner, J
    Vachon, MF
    Champagne, MA
    BONE MARROW TRANSPLANTATION, 2003, 32 (07) : 647 - 651
  • [8] Intravenous busulfan for allogeneic hematopoietic stem cell transplantation in infants: clinical and pharmacokinetic results
    J H Dalle
    D Wall
    Y Theoret
    M Duval
    L Shaw
    D Larocque
    C Taylor
    J Gardiner
    M F Vachon
    M A Champagne
    Bone Marrow Transplantation, 2003, 32 : 647 - 651
  • [9] Intravenous busulfan as part of conditioning regimen in children undergoing allogeneic and autologous haematopoietic stem cell transplantation
    Gomez-Garcia, L.
    Molina, J. R.
    Rodriguez, G.
    Rodriguez-Villa, A.
    Garcia, E.
    Buenasmananas, D.
    Llamas, M. J.
    Chic, C.
    Rojas, R.
    Carmen, M.
    Gomez, P.
    BONE MARROW TRANSPLANTATION, 2013, 48 : S265 - S265
  • [10] Higher incidence of hypertension with intravenous busulfan compared to oral busulfan in thalassaemic children who underwent haematopoietic stem cell transplantation
    Tayfun, F.
    Baytan, B.
    Ozdemir, G. N.
    Akcan, M.
    Uygun, V.
    Karasu, G.
    Yesilipek, A.
    BONE MARROW TRANSPLANTATION, 2011, 46 : S186 - S186